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The CD1d-restricted invariant natural killer T (iNKT) cells are implicated in innate immune 
responses against human immunodeficiency virus (HIV). However, the determinants of 
cellular dysfunction across the iNKT cells subsets are seldom defined in HIV disease. 
Herein, we provide evidence for the involvement of the negative checkpoint regulator 
(NCR) 2B4 in iNKT  cell alteration in a well-defined cohort of HIV-seropositive anti- 
retroviral therapy (ART) naïve, ART-treated, and elite controllers (ECs). We report on 
exaggerated 2B4 expression on iNKT cells of HIV-infected treatment-naïve individuals. 
In sharp contrast to CD4−iNKT cells, 2B4 expression was significantly higher on CD4+ 
iNKT cell subset. Notably, an increased level of 2B4 on iNKT cells was strongly correlated 
with parameters associated with HIV disease progression. Further, iNKT cells from ART-
naïve individuals were defective in their ability to produce intracellular IFN-γ. Together, 
our results suggest that the levels of 2B4 expression and the downstream co-inhibitory 
signaling events may contribute to impaired iNKT cell responses.
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inTrODUcTiOn
Invariant natural killer T (iNKT) cells are a unique subset of T lymphocyte that bridges innate and 
adaptive immune responses (1). In addition to immune regulation, iNKT cell role is also implicated 
in several viral infections (2). In human peripheral blood, iNKT cells constitute a smaller fraction 
ranging between 0.01 and >1% of the total CD3+ T cells (3, 4). iNKT cells express invariant TCR 
Vα24 and Vβ11 chain, and NK cell markers such as CD161 and NKG2D (1). Unlike the classical T 
and B cells, iNKT cells recognize only glycolipid and phospholipid antigens of microbes presented on 
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CD1d, a non-polymorphic major histocompatibility complex class 
I (MHC class I)-like molecule (5). Upon activation, iNKT cells 
rapidly produce large amounts of both IFN-γ (Th1) and IL-4 
(Th2) cytokines to regulate host immune responses. Functionally, 
iNKT cells can be classified into CD4− (Th1cytokine-expressing) 
and CD4+ (Th1 and Th2 cytokine-producing) subsets. The 
CD4−iNKT  cells can further be divided into CD8+ as well as 
CD4− CD8− (double negative-DN) populations. CD8+iNKT cell 
predominantly exhibits a Th1 phenotype. Evidence suggests that 
CD4+ and CD4−iNKT cell homeostasis significantly impact the 
functional outcome of immune responses in the host (6, 7).
Negative checkpoint regulators (NCRs) such as cytolytic T lym-
phocyte-associated antigen-4 (CTLA-4), T-cell immunoglobulin 
mucin-3 (TIM-3), programmed death-1 (PD-1), 2B4 (CD244), 
lymphocyte activation gene-4 (LAG-3), and CD160 play a critical 
role in the regulation of anti-viral CD8+ T cell responses during 
human immunodeficiency virus (HIV) infection (8). Persistent 
antigen exposure and immune activation during chronic HIV 
infection lead to the upregulation of these molecules, initiating 
CD8+ T  cell exhaustion and functional immune impairment 
(9, 10). The initiation of anti-retroviral therapy (ART) has been 
shown to dampen the expression of some of the regulatory mol-
ecules to normal levels (11, 12). In a latest development, NCRs such 
as PD-1, the T cell immune receptor with Ig and ITIM domains 
(TIGIT) and LAG-3 have been proposed to harness HIV persis-
tence (13). Akin to that in CD8+ T cells, some of the NCRs have 
also been shown to suppress iNKT cell functions. For instance, 
upregulation of PD-1 on iNKT cells of ART-naïve individuals is 
associated with poor cell function (14). The NK cell receptor 2B4 
belongs to the signaling lymphocyte activation molecule (SLAM) 
family of proteins that binds to a high-affinity ligand CD48 (15) 
and transduces signal via immune receptor tyrosin-based switch 
motif (ITSM) (16). 2B4 has previously been shown to regulate 
both T and NK cell anti-viral responses (17). Earlier studies have 
hinted that 2B4 could enhance NK and CD8+ T  cell functions 
(18), and recent lines of evidence suggest that 2B4 may possess 
both co-stimulatory as well as co-inhibitory functions (19). For 
instance, a relatively low expression of 2B4 on NK cells has been 
shown to trigger their proliferation and eventual release of IFN-γ, 
while a higher expression resulted in functional suppression of 
HCV-specific CD8+ T cells (20).
Several studies have shown the depletion of iNKT  cells, in 
particular, the CD4+ subset of these cells from the peripheral 
circulation of HIV-infected individuals (21–24). The primary 
cause of such depletion is reportedly attributed to the expression 
of HIV co-receptors, CCR5 and/or CXCR4 on iNKT  cells (21, 
22, 25). Of the iNKT cell subsets, the CD4+ appears to be highly 
susceptible to HIV infection (21, 23). In addition, iNKT cells have 
also been found to be defective in their ability to produce IFN-γ 
in HIV disease (14, 26, 27). Interestingly, ART follow-up studies 
have shown slow and poor recovery of iNKT cells although the 
data were insignificant during the first year of treatment (28, 29).
In contrast to the relatively commonly studied NCRs PD-1, 
TIM-3, and LAG-3, far less is known about the contribution of 
2B4 in iNKT cell regulation in HIV disease. Here, we compared 
the surface levels of 2B4 expression and the associated cel-
lular dysfunction in a well-defined cohort of HIV-seropositive 
ART-naïve, ART-treated, and elite controllers (ECs). We also 
provided evidence of elevated levels of 2B4 on the iNKT cells of 
ART-naïve individuals. Of the iNKT subsets, 2B4 expression was 
significantly higher on CD4+ as compared to the CD4− subset. 
Further, iNKT cells were defective in their ability to produce IFN-γ 
and there was a positive correlation between 2B4+ iNKT cells and 
HIV disease progression. These data advance our understanding 
of iNKT cell regulation during virus insult.
MaTerials anD MeThODs
human subjects
A total of 48 HIV-infected individuals including HIV-seropositive 
(ART-naïve, n = 23), combination ART-treated (cART, n = 19), 
and elite controllers (ECs, n = 6), and HIV-seronegative healthy 
controls (HCs, n  =  15) were recruited into the study. Naïve 
individuals never received ART while treated individuals were on 
ART for at least one year. The ART regimens comprised three or 
four of the following: tenofovir, emtricitaine, nevirapine, retrovir, 
atazanavir, ritonavir, abacavir, zidofovir, saquinavir, fosamprena-
vir, lopinavir, lamivudine, efavirenz, and darunavir. A summary 
of clinical features of all participants is described in Table  1. 
Written informed consents were taken from each participant and 
the study was approved by the Institutional Ethics Committee 
(MEC) and the Institutional Review Board (IRB) of the University 
of Malaya Medical Center (UMMC), Kuala Lumpur, Malaysia 
and the Hannover Medical School, Germany, respectively.
Peripheral Blood Mononuclear cells 
(PBMcs) and immunophenotyping
Peripheral blood mononuclear cells were isolated as described 
before (30, 31) and stored in liquid nitrogen until use. Briefly, 
freshly drawn intravenous blood was subjected to ficoll-hypaque 
gradient centrifugation. 1–2 × 106 PBMCs were first stained with 
fixable viability dye eFluor 506 (eBiosciences) in order to exclude 
dead cells from the sample. APC-conjugated PBS-57-loaded 
CD1d tetramer (NIH Tetramer Core Facility, National Institute 
of Health, Atlanta, GA, USA) and a panel of following antibodies 
were purchased from BioLegends; PECy7-CD3, APC-Cy7-CD3, 
Pacific Blue-CD4, PerCP Cy5.5-CD8, FITC-2B4. Fluorescence-
minus-one (FMO) stain was included to avoid false-positive sig-
nals. Cells were acquired on a BD FACSCanto II flow cytometer 
using FACS Diva software (v.7), and analyzed by FlowJo software 
(v.8.4.4, Tree Star).
cell stimulation and intracellular iFn-γ 
cytokine Detection
Briefly 2–3 ×  106cells were stimulated with 100  ng/ml alpha-
galactosylceramide (α-GalCer, kindly provided by Dr. Paul 
Savage, Brigham Young University, UT, USA) in a 24-well culture 
plate. After 1 h of stimulation, brefeldin-A (10 µg/ml) was added 
and cultured for another 5 h. Cells were harvested and washed 
twice with phosphate buffer saline (PBS) before staining with 
fixable viability dye eFluor 506 exclude dead cell. Cells were then 
surface stained with CD3, CD1d tetramer followed by fixation, 
and permeabilization using Fix/Perm kit (BD biosciences kit) as 
TaBle 1 | clinicodemographic characteristics of study participants.
group numbers 
(n)
age-years  
(median)
sex cD4 count  
(seM)
Viral load  
(median)
cD4/cD8  
(seM)
M F
HC 15 39 10 5 NA NA NA
Naïve 23 38 16 7 330 ± 43.4 67,700 ± 65,935 0.370 ± 0.042
ART 19 53 12 7 528 ± 59.7 ND 0.670 ± 0.052
EC 6 54 4 2 1,066 ± 134 33 ± 59.7 0.99 ± 0.128
CD4 count and CD4/CD8 ratio represented as mean ± SEM while viral load as median ± SEM.
ART, anti-retroviral treated; EC, elite controllers; F, female; HC, healthy controls; Naïve, HIV untreated; M, male; NA, not available; ND, not detected.
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described before (32). Pacific Blue-IFN-γ antibody (BioLegends) 
was added to detect intracellular expression. Cells were washed 
before acquisition by flow cytometer.
statistical analyses
For statistical evaluation of data, we have used GraphPad PRISM 
(v.5.0) software. Unpaired, two-tailed t-test was used to compare 
between two groups or one-way ANOVA followed by Tukey test 
was used for comparing more than two groups. To determine cor-
relation, Pearson analysis was employed. P values of <0.05 were 
considered significant.
resUlTs
cD4+ inKT cell subset Was Preferentially 
lost from the circulation of hiV-Positive 
Treatment-naïve Patients, and arT Failed 
to restore cD4+ inKT cell Frequency
To investigate the size of iNKT cell pool in the peripheral blood of 
different study groups, we employed a flow cytometric approach 
using iNKT  cell-specific PBS 57-loaded/CD1d tetramer and 
anti-CD3 antibody (Figure  1A). Taking into consideration the 
scarcity of iNKT cells in peripheral blood, we applied a stringent 
gating strategy during cell acquisition and data analysis (Figure 
S1 in Supplementary Material). Fluorescence-minus-one (FMO) 
staining was used to determine the threshold values for expres-
sion of the specific markers. Consistent with previous reports 
(23, 33), a substantial loss of iNKT cells was observed in ART-
naïve individuals (mean 0.04 ± 0.009%, P = 0.008) in comparison 
with healthy controls (HCs) (mean 0.16 ± 0.048%) (Figure 1C). 
Interestingly, the frequency in ART subjects remained low (mean 
0.04 ± 0.012%, P = 0.017) in relation to HCs. Notably, the ini-
tiation of ART regimens was unable to completely reconstitute 
iNKT  cell numbers. However, the frequency of iNKT  cells in 
ECs (mean 0.06 ±  0.037%) was more or less similar as HCs 
(P = 0.502). The data from EC cohort suggest that in addition 
to infection of iNKT cells by HIV, on-going HIV replication may 
act as an additional factor contributing significantly to iNKT cell 
depletion from peripheral blood.
As described, iNKT cells can be broadly divided into CD4− 
and CD4+ subsets (6), hence we sought to examine the frequency 
of these two subsets during HIV infection. We labeled the cells 
with CD1d tetramer, anti-CD3, and anti-CD4 antibodies and 
analyzed it through flow cytometry (Figure  1B). We observed 
severe depletion of CD4+ iNKT cell subset in ART-naïve subjects 
(mean 11.13  ±  1.65%, P  =  0.0001) (Figure  1D). This could 
probably be due to HIV infection and subsequent loss of CD4+ 
iNKT cells. Interestingly, the cell frequency remained lower in the 
ART cohort (mean 16.11 ± 3.12%, P = 0.001) compared to HCs 
(mean 37.47 ± 5.51%), suggestive of the lack of appreciable recon-
stitution of CD4+ iNKT cells despite receiving ART. Nonetheless, 
the CD4+ iNKT cell distribution in ECs was more or less similar 
to that seen in HCs (P = 0.549).
Next, we sought to estimate the CD4−iNKT  cell subset 
(Figure 1B). Interestingly, there was a marked increase in the cell 
frequency among ART-naïve (mean 88.60 ± 1.66%, P = 0.0001) 
individuals as compared to HCs (mean 62.51 ± 5.49%) (Figure 1E). 
However, we did not observe any significant impact in the ART 
patient group as frequency of CD4−iNKT  cell continued to 
remain higher. Appearance of relatively higher CD4−iNKT cells 
is believed to be mainly contributed by CD8+ iNKT cells (33).
expression of 2B4 Was significantly 
Upregulated on Bulk of cD3+ T cells of 
arT-naïve individuals
Given that a complex network of co-stimulatory and co-inhibitory 
molecules regulate T  cell immune responses (8), and that dif-
ferential expression of some of the well characterized molecules 
(PD-1, CD160, TIM-3, LAG-3, and 2B4) has already been shown 
to severely affect antigen-specific CD8+ T-cell responses, espe-
cially in HIV and HCV (10, 34–36) infections, their expression on 
iNKT cells of chronic viral diseases are yet to be investigated. Given 
the suppressive role of 2B4 in HIV-specific CD8+ T cells (10), we 
examined the levels of 2B4 expression on T cell subsets including 
CD3+, CD4+, and CD8+ T cells (Figure 2A). The expression of 
2B4 was markedly increased on bulk CD3+ T cells of ART-naïve 
(mean 42.23 ± 4.06%, P = 0.0009), and relatively less significantly 
in ART-treated individuals (mean 34.56 ± 5.58%, P = 0.041) as 
compared to HCs (mean 18.91 ± 3.89%) (Figure 2B). However, 
the differences of 2B4 were not significant between ART-treated 
and treatment-naïve individuals (P = 0.27), whereas ECs showed 
comparable expression pattern with respect to HCs.
Next, we sought to examine the level of 2B4 expression on 
CD4+ T cells. We observed very low 2B4 expression as compared 
to bulk CD3+ and CD8+ T cells. Further, there was no significant 
difference when both ART-naïve and ART subjects were compared 
with HCs, despite an apparent increase in 2B4 expression across 
both the study groups (Figure 2C). These data strongly suggest 
an induction of 2B4 on T cells during HIV infection. In contrast 
FigUre 1 | Frequency of cD1d-restricted invariant natural killer T (inKT) cells and their subsets. Frozen peripheral blood mononuclear cells (PBMCs) from 
healthy controls (HCs, n = 15), human immunodeficiency virus-seropositive (ART-naïve, n = 23), ART-treated (ART, n = 19), and elite controllers (ECs, n = 6) were 
stained with PBS-57 loaded/CD1d tetramer, anti-CD3, and anti-CD4 antibodies before acquisition by flow cytometer. A detailed gating strategy is described in 
Figure S1 in Supplementary Material. (a) Representative FACS plot from an individual of each cohort, numbers indicate percent CD1d Tet+ iNKT cells.  
(B) Representative plot showing percent of CD4+ and CD4− sub-population within the CD1d tet+ iNKT cell-gated population. (c) Scatter plot showing a summary of 
CD1d tet+ iNKT cells frequency across the various study cohorts. (D) Frequency of CD4+ iNKT cells and CD4−iNKT cells (e) in various cohorts. *P < 0.05, 
**P < 0.01, ***P < 0.001, and n.s. stands for non-significant.
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to CD4+ T cells, CD8+ T cells displayed significantly higher levels 
of 2B4 in ART naïve (mean 60.95 ± 5.11%, P = 0.01) as com-
pared to HCs (mean 37.34 ± 8.55%) (Figure 2D). Furthermore, 
individuals who received ART exhibited significantly lower 2B4 
(mean 44.13 ± 6.02%, P = 0.041) levels as compared to ART-naïve 
subjects. Our observations are in line with previous findings 
where 2B4 expressions on virus-specific CD8+ T cells declined to 
normal levels following the initiation of ART (10, 20). In general, 
the basal levels of 2B4 expression on CD4+ cells appeared to be 
lower than CD8+ T cells (Figure S2A in Supplementary Material).
2B4 expression Was higher in Treatment-
naïve individuals and arT initiation Failed 
to normalize 2B4 levels on inKT cell 
subsets
Experimental evidence suggests that 2B4 levels were elevated on 
CD4, CD8, and NK cells during chronic HCV and HIV (10, 20) 
infections. Nonetheless, the expression of 2B4 on iNKT cells has 
seldom been investigated. Here, we endeavored to investigate 
2B4 expression using flow cytometry across the study groups. We 
found significantly higher levels of 2B4 expression in ART-naïve 
individuals as compared to HCs, ART and ECs (Figure 3A). The 
expression was ~2-fold higher in ART-naïve (mean 61.30 ± 4.13%, 
P = 0.0003) than HCs (mean 34.10 ± 5.34%) (Figure 3B). The 
ART-treated subjects showed significantly lower 2B4 levels (mean 
46.47 ± 5.70%, P = 0.037) as compared to ART naïve indicating 
that treatment initiation led to marked downregulation of 2B4 
expression. On the other hand, ECs with apparently suppressed 
HIV replication, exhibited more or less similar levels of 2B4 as 
compared to HCs.
Next, we determined to examine the expression of 2B4 on the 
different iNKT cell subsets (Figure 3A). CD4+ cells of ART-naïve 
individuals showed significantly higher 2B4 expression (mean 
28.48 ± 3.24%, P = 0.013) relative to HCs (mean 14.94.34 ± 4.08%) 
(Figure 3C). Of note, ECs exhibited significantly lower levels of 
2B4 as compared to ART-naïve (P = 0.007) subjects suggesting 
that lack of HIV replication failed to induce 2B4 expression on 
FigUre 2 | expression pattern of 2B4 molecule on cD3, cD4, and cD8 T cells. (a) Representative FACS plots showing percent 2B4 expression on total CD3 
(upper panel), CD4 (middle panel), and CD8 (lower panel) from different cohorts. Fluorescence-minus-one (FMO) staining was used to determine the threshold 
values for the expression of specific markers. (B) Scatter plot showing the mean percentage 2B4 expression on CD3+ T cells of various cohorts, HCs (n = 9), ART 
naïve (n = 15), ART (n = 11), and ECs (n = 6); whereas (c,D) represent the mean percentage of 2B4 expression levels on CD4+ and CD8+ T cells, respectively. 
*P < 0.05, ***P < 0.001, and n.s. stands for non-significant value.
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CD4+ iNKT cell subsets from ECs. However, we did not observe 
any apparent decrease in 2B4 in ART-treated individuals, sug-
gesting that treatment initiation seldom had any effect on 2B4 
expression. Although there was an increase in 2B4 in ART-naïve 
and ART-treated individuals as compared to HCs, this, however, 
failed to reach a significant value (Figure  3D). It should be 
noted that the baseline 2B4 expression on CD4−iNKT cells was 
always greater than that of the CD4+ subsets (Figure S2B in 
Supplementary Material). Together, our data suggest that HIV 
infection leads to the induction of 2B4 on bulk T cells as well as 
on their subsets, especially the CD4+ iNKT cells.
expression of 2B4 on inKT cells inversely 
correlated with intracellular Production of 
iFn-γ
Rapid production of large amounts of IFN-γ is the hallmark 
of activated iNKT  cells. Hence, we assessed the ex vivo ability 
of peripheral iNKT  cells to produce IFN-γ post α-GalCer 
stimulation. We performed intracellular IFN-γ cytokine staining 
of PBMCs obtained from the various study groups. After surface 
staining, cells were permeabilized and subsequently labeled with 
anti-IFN-γ antibody. Cells were gated on CD3+ CD1d-tetramer+ 
population and investigated for IFN-γ production (Figure 4A). 
As compared to HCs (mean 34.23 ± 7.12%), we observed ~2-fold 
lower production of IFN-γ by iNKT  cells of ART-naïve indi-
viduals (n = 15, mean 15.74 ± 2.33%, P = 0.0069) (Figure 4B). 
ART-treated individuals, despite the on-going residual immune 
reconstitution, failed to produce optimal levels of intracellular 
IFN-γ.
Next, to understand the impact of increased levels of 2B4 
on intracellular IFN-γ production, we surface-stained the cells 
for 2B4 and performed standard 6-h stimulation experiments. 
However, we were unable to detect 2B4 surface expression during 
cell acquisition, which most likely could be due to the downregu-
lation of 2B4 after α-GalCer stimulation as shown previously in 
the case of CD8+ T  cells, where a similar observation ensued 
following antigenic stimulation (37). Therefore, in an attempt to 
FigUre 3 | expression levels of 2B4 on invariant natural killer T (inKT) cells and their subsets. (a) Representative zebra plot showing percent 2B4 
expression on iNKT cells of representative individuals from various cohorts. iNKT cells (PBS-57 loaded/CD1d-tetramer+ CD3+) gated population was looked for 
surface 2B4 levels (upper panel). While 2B4 expression on CD4+ (middle panel) and CD4−iNKT cell subset (lower panel) were first gated on CD4+ and CD4− 
population then presented with FSC-A (Y-axis). (B) Scatter plot showing the mean percentage of 2B4 levels on bulk iNKT cells of HCs (n = 15), ART naïve (n = 23), 
ART (n = 19), and ECs (n = 6). Mean percentage of 2B4 levels on CD4+ (c) and CD4−iNKT cell subsets (D). Fluorescence-minus-one (FMO) was taken to exclude 
false-positive values for 2B4. *P < 0.05, ***P < 0.001, and n.s. stands for non-significant value.
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understand the potential relationship between 2B4+ and IFN-γ+ 
iNKT cells, we performed a correlation analysis. Interestingly, we 
observed a significant inverse correlation (r = −0.577, P = 0.030, 
Figure 4C). These data indirectly indicate the association between 
the levels of 2B4 and iNKT cell functionality.
higher expression of 2B4 on inKT cells 
correlated with hiV Disease Progression
In order to understand the relevance of 2B4 expression on 
iNKT cells with HIV disease, a correlation analysis was performed 
between 2B4+ iNKT cells of ART-naïve cohort and known clinical 
parameters of HIV disease progression such as viral load, CD4 
count, and CD4/CD8 ratio. We found a positive correlation 
(r =  0.434, P =  0.038) between 2B4+ iNKT cell frequency and 
the viral load (Figure 5A). Similar analyses were performed with 
CD4 counts and CD4/CD8 ratio. Notably, we observed an inverse 
correlation (r = −0.430, P =  0.040) between 2B4+ iNKT  cells 
and CD4 counts (Figure  5B), and CD4/CD8 ratio (r = −448, 
P = 0.031) (Figure 5C). Taken together, our data suggest that high 
levels of 2B4 expression could likely determine the functionality 
of iNKT cells in HIV infection.
DiscUssiOn
Negative checkpoint regulators, also known as negative regulatory 
molecules, play a key role in shaping T-cell immune responses 
against chronic viral infections. A vast majority of previous 
studies are based on molecules expressed by virus-specific CD8+ 
T  cells both in  vivo (36) and in  vitro (34, 35, 38). However, a 
similar observation is lacking for innate lymphocytes, such as 
iNKT  cells. Here, we report for the first time, the relationship 
between the levels of 2B4, a co-inhibitory molecule, and their 
impact on iNKT cell dysfunction in HIV infection. Using a large 
cohort of HIV-seropositive ART-naïve, ART-treated, and ECs, 
we examined the phenotypic and functional alterations across 
the peripheral iNKT  cell compartment. Here, we observed an 
upregulation of 2B4 on CD1d-restricted iNKT  cells of ART-
naïve individuals. Among the iNKT cell subsets, CD4+ expressed 
significantly higher 2B4 levels as compared to the CD4− phe-
notypes. We also found the existence of a strong association 
between 2B4 expression and loss of CD4+ iNKT cells. Further, 
the 2B4+ iNKT  cells of ART-naïve cohort positively correlated 
with HIV viral load and inversely with CD4 count and CD4/CD8 
FigUre 4 | invariant natural killer T (inKT) cell production of iFn-γ and their association with 2B4 levels. (a) Representative plot from each cohort 
showing percentage of intracellular IFN-γ expression. α-GalCer-stimulated peripheral blood mononuclear cells (PBMCs) were surface-labeled with PBS-57 loaded/
CD1d tetramer and CD3 followed by intracellular staining with anti-IFN-γ antibody as described in the section “Materials and Methods.” iNKT cell-gated population 
were looked for IFN-γ production. (B) Scatter plots show mean percentages of IFN-γ production by each cohort HCs (n = 8), ART naïve (n = 14), ART (n = 10), and 
ECs (n = 6). **P < 0.01 and n.s. stands for non-significant. (c) Plot showing the correlation between 2B4+ iNKT cells and IFN-γ production by ART-naive cohort 
(n = 14).
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ratio. Finally, we also found that the iNKT cell phenotypes were 
functionally impaired in their ability to produce the intracellular 
anti-viral cytokine IFN-γ whose levels inversely correlated with 
the expression of 2B4.
Recent studies have shed light on the anti-viral functions of 
iNKT cells in HBV, HCV, and HIV infections (2). With regard 
to HIV, there appears to be a rapid depletion of iNKT cells from 
the periphery of infected individuals (23). Further, a recent 
study has shown the early loss of peripheral CD4+ iNKT  cells 
post-HIV infection, and reported a more profound depletion 
than the classical CD4+ T  cells (33). In addition to overall 
iNKT  cell depletion from the periphery, our study has clearly 
shown the selective depletion of CD4+ iNKT cells as compared 
to the CD4− subset. It should be noted that CD4+ iNKT  cell 
depletion was associated with increased CD4− cell numbers 
both in HIV-naïve and ART-treated individuals, an interest-
ing observation, which has seldom been reported in the past 
(22, 39). Since we did not observe similar effects with respect to 
ECs, our data suggest that in addition to cell death due to direct 
infection of CD4+ iNKT cells (40), on-going viral replication and 
subsequent immune activation (41) could likely play a role in 
activation-induced cell death (AICD) of activated iNKT  cells. 
One of the limitations of our study is the scarcity of EC samples, 
which represents a rare population of HIV-infected individuals. 
Perhaps, the inclusion of more samples from this cohort could 
have been more informative. Nevertheless, data obtained from 
our EC study seemingly reflect iNKT cell behavior during HIV 
infection. We would like to mention that our cohorts comprised 
different age range and male/female participants that might 
impact the iNKT cell frequencies. Nonetheless, we succeeded in 
keeping the age and sex of HC (median age = 39), ART naïve 
(median age = 38) very much comparable except ART and EC 
study groups where median age was slightly higher. Since HC and 
ART naïve represent the two key study groups to describe the 
effects of HIV on iNKT cell impairments, and hence, a slight age 
difference with ART and EC may not greatly affect the outcome 
of our findings. However, a study involving large cohorts of male 
and female participants indicates that gender and age do not have 
an impact on iNKT cell frequencies (3).
Initial studies have suggested 2B4 as a co-stimulatory receptor 
to enhance NK and CD8+ T cell functions (18, 42). However, a 
number of recent studies have shown 2B4 to act as both activating 
as well as inhibitory receptor on NK cells (43) and HCV-specific 
CD8+ T  cells (20). High-level expression of 2B4 and other 
inhibitory receptors has also been observed on exhausted LCMV-
specific CD8+ T cells (44) and HIV (45). Interestingly, blockade 
of 2B4–CD48 interactions has been shown to restore LCMV (46) 
and human HBV-specific (47) CD8+ T  cell effector functions 
in  vitro culture. Furthermore, absence of mouse 2B4 has been 
described to promote NK cell-mediated killing of activated CD8+ 
FigUre 5 | correlation between frequency of 2B4+ inKT cells and human immunodeficiency virus (hiV) disease progression. (a) Correlation plot 
between frequency of 2B4+ iNKT cells versus HIV viral load (n = 23) (B) CD4 counts (n = 23) and (c) CD4/CD8 ratio (n = 23).
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T cells (48). These data support our finding that high levels of 
2B4 expression contribute to iNKT  cells inhibition. Generally, 
the dual function of 2B4 depends on surface expression level 
and downstream signaling involving SAP. Although the dual role 
of 2B4-mediated regulation of virus-specific CD8+ T  cells has 
recently been reported (20), we are not certain if a similar phe-
nomenon also occurs for CD4−iNKT (CD8+ and DN) cells, as this 
subset too exhibits elevated 2B4 expression. Hence, more data are 
required to address this feature in HIV infection. Nevertheless, 
the current experimental results point to an inhibitory role for 
2B4 expressed on iNKT  cells. The strong association between 
iNKT cell depletion and 2B4 levels, and inverse correlation with 
IFN-γ production clearly supports this hypothesis. Although we 
did not show the evidence in support, there is a high likelihood 
that the CD4+ subset could potentially have been infected with 
HIV (40) exhibiting high levels of 2B4, and that were selectively 
depleted during HIV infection. However, these studies require 
further investigation to completely explore the underlying 
mechanisms.
Our data further showed an impaired ability of ART-naïve 
iNKT cells to produce IFN-γ. ART-treated individuals failed to 
restore iNKT cell functions despite years of treatment. We were 
unable to show the expression of IFN-γ+ iNKT cells in standard 
6-h in  vitro stimulation experiments potentially due to down 
modulation of 2B4 expression post-α-GalCer stimulation. One 
such study has reported this observation where TCR and 2B4 
signals were shown to downmodulate 2B4 expression on T cells of 
HIV-infected individuals (37). Nonetheless, the correlation plot 
drawn between 2B4+ iNKT cells and IFN-γ+ iNKT cells clearly 
indicates an inverse association, supporting the notion that 2B4 
signaling indeed could lead to suppressed iNKT cell functions. 
This correlation study is based on data obtained from two separate 
experiments examining 2B4 expression and intracellular IFN-γ 
production. We were able to include only 14 out of 23 ART-naïve 
samples representing adequate number of cells to perform both 
2B4 and IFN-γ expression. However, due to fewer number of cells 
in the remaining nine ART-naïve samples, we could only perform 
2B4 but not IFN-γ expression.
Of note, the clinical significance and relevance of elevated 
iNKT cell 2B4 expression are clearly supported by the correlation 
data. The positive correlation with HIV viral load and negative 
association with CD4 count and CD4/CD8 ratio further supports 
our finding that 2B4 indeed could serve as a potential determi-
nant of iNKT cell dysfunction. We speculate that on-going HIV 
replication in ART-naïve individuals may be one of the factors 
that drive the enhanced 2B4 expression on iNKT cells hence the 
functionality, thus warrants further investigation. Further studies 
are required to understand the mechanisms and signaling events 
that might trigger iNKT cell inhibition. Potential blockade of 2B4 
could provide a clear impetus to understand the factors underly-
ing the restoration of iNKT cell effector functions. Overall, our 
data have clearly revealed the association of 2B4 in iNKT  cell 
impairment during HIV infection.
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FigUre s1 | gating strategy to identify invariant natural killer T (inKT) 
cells and their subsets. Frozen peripheral blood mononuclear cells (PBMCs) 
were labeled with PBS-57 loaded/CD1d tetramer, CD3, CD4, and live–dead stain 
(a). Initially, cells were gated on lymphocytes based on SSC-A and FSC-A 
followed by exclusion of doublet cells using FS-A and FSC-H (B). Singlet cells 
were gated for live cells by excluding the live–dead cell stain positive population 
(c). Live cells were gated on CD3+ T cells population (D). CD3+ T cells were 
further gated to identify iNKT cells (CD1d tet+ CD3+ cells) (e). iNKT cells were 
further gated to detect CD4+ and CD4− subsets (F).
FigUre s2 | (a) Basal levels of 2B4 expression. Part of the data is adapted 
from Figure 2, 2B4 expression was re analyzed only in healthy donors. CD3+ 
T cell-gated cells were further gated for 2B4 expression on CD4+ and CD8+ T cell 
populations. (B) Healthy donor data were adapted from Figure 3. CD1d tet+ 
CD3+ iNKT cells were gated for 2B4 expression on CD4+ and CD4− subsets.
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